Tratamentul bolilor alergice în timpul sarcinii.

Allergic diseases, including allergic rhinitis/ rhinoconjuctivitis, asthma, and urticaria, are common conditions in the adult population, affecting women at the fertile age. Although, ideally, pregnant women should not receive pharmacologic treatment because of associated risks for the unborn child, sometimes quality of life impairment or risks of associated complications make medication necessary. The benefit/risk ratios associated with treatment in allergic diseases are favourable and allow the safe administration of several pharmacological classes. Oral antihistamines, predominantly loratadine and cetirizine, have a good safety profile in pregnant women. Treating asthma is extremely important because of the risks associated with the disease, and the preferred treatment is inhaled corticosteroids, and other classes of antiasthmatic drugs can also be administered. Allergen-specific immunotherapy can be continued during pregnancy safely, and some studies suggest a possible protective effect on the subsequent development of allergic diseases in the child. [ABSTRACT FROM AUTHOR]